SMTL ID : 4dsy.2 (1 other biounit)

Crystal structure of red kidney bean purple acid phosphatase in complex with Maybridge fragment CC24201

Coordinates
PDB Format
Method
X-RAY DIFFRACTION 2.30 Å
Oligo State
homo-tetramer
Ligands
7 x NAG- FUC- NAG: alpha-L-fucopyranose-(1-3)-[2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)]2-acetamido-2-deoxy-beta-D-glucopyranose(Non-covalent)(Post Translational Modification)(Non-functional Binders)
2 x NAG- FUC: alpha-L-fucopyranose-(1-3)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
4 x ZN: ZINC ION(Non-covalent)
4 x FE: FE (III) ION(Non-covalent)
1 x 0LO: 5-phenylpyridine-3-carboxylic acid(Non-covalent)
7 x GOL: GLYCEROL(Non-functional Binders)
7 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
11 x SO4: SULFATE ION(Non-functional Binders)
13 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
2 x ACT: ACETATE ION(Non-functional Binders)
Links
RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP
Citation
Feder, D. et al., Identification of purple acid phosphatase inhibitors by fragment-based screening: promising new leads for osteoporosis therapeutics. Chem.Biol.Drug Des. (2012)
Release Date
2012-09-19
Peptides
Purple acid phosphatase: ABCD
SMTL:PDB
SMTL Chain Id:
PDB Chain Id:
A
A
B
B
C
C
D
D

Purple acid phosphatase

Toggle Identical (BD)

Related Entries With Identical Sequence

4dhl.1 | 4dhl.2 | 4dsy.1 | 4dt2.1 | 4dt2.2 | 6g46.1 | 6hwr.1 | 6hwr.2 | 6of5.1 | 6of5.2 | 6of5.3 | 6vj7.1